Naveen Kathuria

Naveen Kathuria is the Chief Executive Officer of GoCheck Kids, a Nashville-based mobile software company that provides vision screening technology for children.13 He was appointed to this position in early 2023, bringing with him a wealth of experience in healthcare technology and entrepreneurship.1

Background and Experience

Kathuria's professional journey is diverse and impressive:

• Legal and Corporate Background: He began his career as an attorney, management consultant, and investment banker.1
• Entrepreneurial Shift: About a decade ago, Kathuria transitioned into entrepreneurship, focusing on building medical wellness clinics and telehealth startups.1
• Previous CEO Role: Prior to joining GoCheck Kids, he served as the CEO of eFamilyCare, a digital platform supporting family caregivers in New York.1
• Education: Kathuria attended Boston University School of Law.2

Vision and Leadership at GoCheck Kids

As CEO of GoCheck Kids, Kathuria is focused on:

1. Expanding Access: His goal is to increase the number of children who have access to GoCheck's vision screening technology, regardless of their location.1
2. Targeting Underserved Populations: He plans to grow the company's presence in Federally-Qualified Health Centers and Native American tribes.1
3. Team Leadership: Kathuria is leading a hybrid team of over 40 people, emphasizing a non-hierarchical structure and encouraging input from all team members.1

Philosophy and Approach

Kathuria's leadership style is characterized by:

• Passion for Healthcare Accessibility: He is dedicated to making healthcare more accessible to vulnerable populations.1
• Emphasis on Authenticity: He believes in creating an environment where people can be themselves and are inspired by their work.1
• Collaborative Leadership: Kathuria values input from all team members, regardless of their role in the company.1

Under Kathuria's leadership, GoCheck Kids aims to continue its mission of impacting children's lives through early vision screening, having already helped over 4 million patients to date.1